Holen Sie sich die Stockscreener-App
4.55
0.89%
-0.04
Schlusskurs vom Vortag:
$4.51
Offen:
$4.5
24-Stunden-Volumen:
7,535
Relative Volume:
0.18
Marktkapitalisierung:
$81.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.46M
KGV:
-0.1572
EPS:
-28.9457
Netto-Cashflow:
$-8.70M
1W Leistung:
-1.11%
1M Leistung:
+0.45%
6M Leistung:
+25.92%
1J Leistung:
-10.92%
1-Tages-Spanne:
$4.45
$4.545
1-Wochen-Bereich:
$4.45
$4.72
52-Wochen-Spanne:
$2.66
$5.8922
Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile
Firmenname
Alterity Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare ATHE vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATHE
Alterity Therapeutics Ltd Adr
|
4.50 | 82.12M | 0 | -9.46M | -8.70M | -28.95 |
VRTX
Vertex Pharmaceuticals Inc
|
521.01 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
802.50 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.97 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.20 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.57 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alterity Therapeutics Ltd Adr Stock (ATHE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-03 | Herabstufung | The Benchmark Company | Speculative Buy → Hold |
| 2024-12-12 | Eingeleitet | Maxim Group | Buy |
Alterity Therapeutics Ltd Adr Aktie (ATHE) Neueste Nachrichten
Immuron LimitedADR (IMRN) Peer Comparison – Compare with Others - Value Research
Alterity Therapeutics Reports A$17.6M in R&D Expenses for Fiscal Year Ending June 30, 2026 - Kalkine Media
Kazia Therapeutics LimitedADR Peer Comparison – Compare with Others - Value Research
Alterity Therapeutics Limited (ASX:ATH) Share Price Falls 4.46% as Stock Trades Within Daily Range - Kalkine
Alterity Therapeutics Secures Key US Patent for Lead Asset - Sahm
Alterity Therapeutics at Canaccord conference: phase III path in focus By Investing.com - Investing.com India
Alterity Therapeutics at Canaccord conference: phase III path in focus - Investing.com
Craig-Hallum initiates Alterity Therapeutics stock coverage with buy rating - Investing.com
Acrux Ltd (ASX:ACR) Share Price Update: Trading Snapshot for 11 August 2026 - Kalkine
Alterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key SupportFibonacci Fan - vinanet.vn
PRNAF SEC FilingsALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Weiss Ratings Stock Recommendations & Analyst Ratings 2026 - MarketBeat
ATHE News | ALTERITY THERAPEUTICS-ADR (NASDAQ:ATHE) - ChartMill
[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) | ATHE SEC FilingForm 6-K - Stock Titan
Jones Trading initiates Alterity Therapeutics stock with buy rating - Investing.com
Alteriry Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ATHE) - TradingView
Is Allarity Therapeutics, Inc. (ALLR) outperforming other medical stocks this year? - MSN
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alterity Therapeutics Advances Lead Drug Towards Pivotal Study For Rare Neuromuscular Disorder - Sahm
Insights: Alterity Therapeutics Ltd (ASX:ATHDA) - smallcaps.com.au
ATHEAlterity Therapeutics Ltd ADR Short Interest - Finviz
Alterity Therapeutics (NASDAQ: ATHE) sets vote on 50:1 consolidation and large option, incentive issuances - Stock Titan
Alterity Therapeutics appoints Ann Cunningham to board - Investing.com
Alterity Therapeutics appoints Ann Cunningham to board By Investing.com - Investing.com India
Nerves settle as oil drops - The Cairns Post
Alterity Therapeutics Receives Positive FDA Feedback for ATH434 Phase 3 MSA Program - smallcaps.com.au
ATA Inc. (NASDAQ:AACG) Sees Large Decline in Short Interest - Defense World
Actelis Networks, Inc. (NASDAQ:ASNS) Sees Large Decline in Short Interest - Defense World
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
Ameritas Investment Partners Inc. Raises Stock Holdings in Kratos Defense & Security Solutions, Inc. $KTOS - Defense World
Alterity Therapeutics (NASDAQ:ATHE) Upgraded at Zacks Research - Defense World
Insights: Alterity Therapeutics Ltd (ASX:ATH) - smallcaps.com.au
Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434 - Finviz
Quantum Biopharma (QNTM) Short Interest & Short Float | Updated May 2026 - MarketBeat
Liminatus Pharma (LIMN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Jason McCarthy Analyst Performance at Maxim Group - MarketBeat
ATHE SEC FilingsAlterity Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Alterity Therapeutics LtdADR (ATHE) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
- SEC.gov
Cadrenal Therapeutics (CVKD) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Bullfrog AI (BFRG) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Imunon (IMNN) Short Interest & Short Float | Updated May 2026 - MarketBeat
What is the current Price Target and Forecast for Alterity Therapeutics LimitedSponsored ADR (ATHE) - Zacks Investment Research
Mainz Biomed (MYNZ) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
These stocks are moving in today's pre-market session - ChartMill
Portage Biotech (PRTG) Short Interest & Short Float | Updated Apr 2026 $PRTG - MarketBeat
Which stocks are gapping on Wednesday? - ChartMill
Which stocks are moving before the opening bell on Thursday? - ChartMill
Friday's session: gap up and gap down stocks - ChartMill
Finanzdaten der Alterity Therapeutics Ltd Adr-Aktie (ATHE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):